Aqua Bio Technology ASA 

kr5.1
4083
+kr0+0% Thursday 14:10

Statistics

Day High
5.28
Day Low
5.02
52W High
100
52W Low
4.7
Volume
6,236
Avg. Volume
-
Mkt Cap
8.86B
P/E Ratio
-
Dividend Yield
459.14%
Dividend
23.42

Upcoming

Dividends

459.14%Dividend Yield
May 26
kr5.91
Feb 26
kr6.37
Nov 25
kr5.96
Aug 25
kr6.04
May 25
kr6.28
10Y Growth
9.25%
5Y Growth
6.96%
3Y Growth
7.3%
1Y Growth
6.78%

Earnings

16JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
1.07
1.21
1.36
1.5
Expected EPS
1.280724
Actual EPS
N/A

Financials

14.71%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
896.69BRevenue
131.88BNet Income

Analyst Ratings

729.64Average Price Target
The highest estimate is 836.93.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABTEC.OL. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap547.64B
Johnson & Johnson competes with Abbott in multiple segments including medical devices, diagnostics, and pharmaceuticals, making it a direct competitor across several of Abbott's business lines.
Medtronic
MDT
Mkt Cap106.97B
Medtronic competes with Abbott in the medical devices sector, particularly in cardiovascular and diabetes care products.
Thermo Fisher Scientific
TMO
Mkt Cap174.55B
Thermo Fisher Scientific competes with Abbott in the diagnostics and life sciences sector, offering a range of analytical instruments, reagents, and consumables.
Danaher
DHR
Mkt Cap125.45B
Danaher Corporation competes with Abbott in the diagnostics and life sciences industry, particularly through its subsidiary Cepheid, which offers molecular diagnostics solutions.
Boston Scientific
BSX
Mkt Cap92.25B
Boston Scientific competes with Abbott in the medical devices sector, especially in cardiovascular products.
Baxter International
BAX
Mkt Cap9.38B
Baxter International competes with Abbott in the medical devices and nutrition sectors, offering products for critical care, nutrition, renal care, and more.
Stryker
SYK
Mkt Cap125.43B
Stryker competes with Abbott in the medical devices sector, particularly in orthopedics, which indirectly competes with Abbott's offerings in other medical device categories.
Becton Dickinson
BDX
Mkt Cap43.28B
Becton, Dickinson and Company competes with Abbott in the medical technology sector, offering devices, laboratory equipment, and diagnostic products.
Resmed
RMD
Mkt Cap32.03B
ResMed competes with Abbott in the health sector by providing medical devices for sleep disorders and respiratory conditions, which complements Abbott's broader medical device portfolio.
Hologic
HOLX
Mkt Cap16.97B
Hologic competes with Abbott in the diagnostics sector, particularly in women's health, where both companies offer a range of diagnostic and medical imaging solutions.

About

Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. The company offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Oslo, Norway.
Show more...
CEO
Mr. Kristian Flaten
Employees
36
Country
Other
ISIN
NO0013735894

Listings

0 Comments

Share your thoughts

FAQ

What is Aqua Bio Technology ASA stock price today?
The current price of ABTEC.OL is kr5.1 NOK — it has increased by +0% in the past 24 hours. Watch Aqua Bio Technology ASA stock price performance more closely on the chart.
What is Aqua Bio Technology ASA stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aqua Bio Technology ASA stocks are traded under the ticker ABTEC.OL.
Is Aqua Bio Technology ASA stock price growing?
ABTEC.OL stock has fallen by -12.97% compared to the previous week, the month change is a -27.19% fall, over the last year Aqua Bio Technology ASA has showed a -83.71% decrease.
What is Aqua Bio Technology ASA market cap?
Today Aqua Bio Technology ASA has the market capitalization of 8.86B
When is the next Aqua Bio Technology ASA earnings date?
Aqua Bio Technology ASA is going to release the next earnings report on July 16, 2026.
What were Aqua Bio Technology ASA earnings last quarter?
ABTEC.OL earnings for the last quarter are 10.76 NOK per share, whereas the estimation was 10.71 NOK resulting in a +0.47% surprise. The estimated earnings for the next quarter are N/A NOK per share.
What is Aqua Bio Technology ASA revenue for the last year?
Aqua Bio Technology ASA revenue for the last year amounts to 896.69B NOK.
What is Aqua Bio Technology ASA net income for the last year?
ABTEC.OL net income for the last year is 131.88B NOK.
Does Aqua Bio Technology ASA pay dividends?
Yes, ABTEC.OL dividends are paid annual. The last dividend per share was 1 NOK. As of today, Dividend Yield (FWD)% is 459.14%.
How many employees does Aqua Bio Technology ASA have?
As of May 02, 2026, the company has 36 employees.
In which sector is Aqua Bio Technology ASA located?
Aqua Bio Technology ASA operates in the Health & Wellness sector.
When did Aqua Bio Technology ASA complete a stock split?
The last stock split for Aqua Bio Technology ASA was on February 27, 2026 with a ratio of 1:50.
Where is Aqua Bio Technology ASA headquartered?
Aqua Bio Technology ASA is headquartered in Oslo, Other.